The DOI matches its Crossref record.
Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic
Open accessAbstract
Background and Purpose—: Hyperacute assessment and management of patients with stroke, termed code stroke, is a time-sensitive and high-stakes clinical scenario. In the context of the current coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus, the ability to deliver timely and efficacious care must be balanced with the risk of infectious exposure to the clinical team. Furthermore, rapid and effective stroke care remains paramount to achieve maximal functional recovery for those needing admission and to triage care appropriately for those who may be presenting with neurological symptoms but have an alternative diagnosis. Methods—: Available resources, COVID-19-specific infection prevention and control recommendations, and expert consensus were used to identify clinical screening criteria for patients and provide the required nuanced considerations for the healthcare team, thereby modifying the conventional code stroke processes to achieve a protected designation. Results—: A protected code stroke algorithm was developed. Features specific to prenotification and clinical status of the patient were used to define precode screening. These include primary infectious symptoms, clinical, and examination features. A focused framework was then developed with regard to a protected code stroke. We outline the specifics of personal protective equipment use and considerations thereof including aspects of crisis resource management impacting team role designation and human performance factors during a protected code stroke. Conclusions—: We introduce the concept of a protected code stroke during a pandemic, as in the case of COVID-19, and provide a framework for key considerations including screening, personal protective equipment, and crisis resource management. These considerations and suggested algorithms can be utilized and adapted for local practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
Chen, R., Wang, K., Yu, J., Howard, D., French, L., Chen, Z., Wen, C., & Xu, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573095 · Cited by 570
Avula, A., Nalleballe, K., Narula, N., Sapozhnikov, S., Dandu, V., Toom, S., Glaser, A., & Elsayegh, D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.077 · Cited by 558
Stroke care during the COVID‐19 pandemic: experience from three large European countries
Bersano, A., Kraemer, M., Touzé, E., Weber, R., Alamowitch, S., Sibon, I., & Pantoni, L. (2020) · European Journal of Neurology · doi:10.1111/ene.14375 · Cited by 353
Stroke in patients with SARS-CoV-2 infection: case series
Morassi, M., Bagatto, D., Cobelli, M., D’Agostini, S., Gigli, G. L., Bnà, C., & Vogrig, A. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09885-2 · Cited by 263
Neurological manifestations and implications of COVID-19 pandemic
Tsivgoulis, G., Palaiodimou, L., Katsanos, A. H., Caso, V., Köhrmann, M., Molina, C., Cordonnier, C., Fischer, U., Kelly, P., Sharma, V. K., et al. (2020) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286420932036 · Cited by 145
Metadata
- Authors
- Khosravani, H., Rajendram, P., Notario, L., Chapman, M. G., & Menon, B. K.
- Venue
- Stroke
- Published
- 2020-06
- Volume
- 51
- Issue
- 6
- Pages
- 1891-1895
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W3013310257
- Cited by
- 238
- References
- 0
- FWCI
- 34.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. https://app.cochat.ai/papers/10.1161/strokeaha.120.029838
- The paper
- Khosravani, H., Rajendram, P., Notario, L., Chapman, M. G., & Menon, B. K. (2020). Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. Stroke. https://doi.org/10.1161/strokeaha.120.029838
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.